![CAS 41081-31-6 | [1,1'-Biphenyl]-4-yl Dimethyl Chlorosilane](/uploads/41320/small/cas-41081-31-6-1-1-biphenyl-4-yl-dimethylfb5b3.jpg)
CAS 41081-31-6 | [1,1'-Biphenyl]-4-yl Dimethyl Chlorosilane
Name: BIPHENYLDIMETHYLSILYL CHLORIDECAS number: 41081-31-6Molecular formula: C14H15ClSiMolecular
Add to Inquiry
Mpeg-dppe
Product abbreviation: mPEG-DPPE. CAS no. :. Molecular weight: 2,000; 3,500; 5000. Package size: 1g,
Add to Inquiry
Mpeg-dspe
Product abbreviation: mPEG-DSPE. CAS no. :. Molecular weight: 2,000; 3,500; 5000. Package size: 1g,
Add to Inquiry
Mpeg-mal
Product abbreviation: mPEG-MAL(propionamide). CAS no. :. Molecular weight: 2K, 5K, 10K, 20K, 40K.
Add to Inquiry
Mpeg-nh2 (ethylene Diamine)
Product abbreviation: mPEG-NH2 (ethylene diamine). CAS no. :. Molecular weight: 2K, 5K, 10K, 20K,
Add to Inquiry
Mpeg-cl#1-50hr
Product abbreviation: MPEG-CL #1-50Hr. CAS no. :. Molecular weight: 2K, 5K, 10K, 20K, 40K. Package
Add to Inquiry
Mpeg-paba
Product abbreviation: mPEG-PABA. CAS no. :. Molecular weight: 2K, 5K, 10K, 20K, 40K. Package size:
Add to Inquiry
Mpeg-dbco
Product abbreviation: mPEG-DBCO. CAS no. :. Molecular weight: 2K, 5K, 10K, 20K, 40K. Package size:
Add to Inquiry
Mpeg-alkyne
Product abbreviation: mPEG-Alkyne. CAS no. :. Molecular weight: 2K, 5K, 10K, 20K, 40K. Package
Add to Inquiry
Snp26-1
Product abbreviation: C46H91NO8. CAS no. :. Molecular weight: 786.23. Package size: 1g, 5g, 10g,
Add to Inquiry
Snp25-1
Product abbreviation: C46H91NO8. CAS no. :. Molecular weight: 786.23. Package size: 1g, 5g, 10g,
Add to Inquiry
Pcbma
Product abbreviation: pCBMA. CAS no. :. Molecular weight: 259.35. Package size: 1g, 5g, 10g, 100g,
Add to Inquiry
Excipient
Excipients are often referred to as "inactive ingredients" because, in drugs, they comprise of everything except the active pharmaceutical ingredients (APIs). Excipient functions range from helping to guarantee the stability and bioavailability of the API to the drug product’s manufacturability to its texture and taste. Excipients are a major component of almost all drugs, as well as foods, cosmetics and dietary supplements.
Advantages of Excipient
Improvised flow
Co-processing of excipient with controlled particle size distribution and particle morphology results in product with superior flow. This has much to do with the spherical shape and even surfaces of the co-processed particles. The improved flowability of the material in turn helps decrease the weight variation problem encountered during the tabletting of a DC formula.
Controlled Release
Certain excipients are designed to modify the release profile of drugs, allowing for controlled or sustained release. This can lead to improved therapeutic outcomes by maintaining plasma drug concentrations within a desired range over an extended period.
Enhanced Bioavailability
Excipients can improve the solubility and absorption of poorly soluble drugs. By employing solubilizers, surfactants, or complexation agents, excipients can increase the dissolution rate of the API, leading to better bioavailability.
Patient Compliance and Acceptance
Excipients contribute to the overall formulation characteristics, such as taste masking, odor reduction, and color enhancement, making medications more palatable and visually appealing. This is especially crucial for pediatric and geriatric populations, where patient compliance can be significantly influenced by the sensory properties of the dosage form.







